National Institute on Alcohol Abuse and Alcoholism (NIAAA)

The mission of the lab is to understand the cellular and molecular mechanisms involved in the development and progression of fibrosis, to explore novel therapeutic targets and to develop effective pharmacotherapies for fibrotic disorders of different etiologies, including alcohol use disorders. We are particularly interested in pursuing a multi-target therapeutic approach to improve treatment efficacy by simultaneously engaging multiple pathogenic...

At some time during their lives, more than 30 percent of U.S. adults surveyed in 2001-2002 had met current diagnostic criteria [i] for an alcohol use disorder (AUD), according to an article in the current issue of the Archives of General Psychiatry . Many of those persons never received treatment, and many others did not receive treatment until well after...

What we do The Section on Clinical Genomics and Experimental Therapeutics (CGET) conducts pre-clinical studies and translational clinical studies with focus on genomics and epigenetics related to the pathophysiology and treatment of alcohol use disorders and addictions. The pre-clinical work focuses on identifying molecular mechanisms involved in addictions, utilizing a wide array of methods including human population genetics, genome wide...

Helping Your Patients with Alcohol-Related Problems. Alcohol contributes to more than 200 health conditions and about 99,000 deaths in the U.S. each year. Yet alcohol-related risks often go unaddressed in healthcare settings.

In this "First Steps to Al-Anon Recovery" podcast, you will hear an interview with Dr. Kenneth Warren, Acting Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), as he discusses current alcoholism research and how it involves family members affected by someone's alcoholism. For more reasons to try Al-Anon, visit al-anon.org. Al-Anon members: Please remember to maintain anonymity...

In this video, you will hear an interview with Dr. Robert Huebner, Director of the Division of Treatment and Recovery Research at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), as he discusses the treatment options for alcohol use disorders, pertaining to the drinker and to the drinker's family members and friends. For more reasons to try Al-Anon, visit...

Wednesday, April 17, 2024, 8:00 am EDT to Thursday, April 18, 2024, 12:00 pm EDT

A workshop sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA)

In this "First Steps to Al-Anon Recovery" podcast, you will hear an interview with Dr. George Koob, Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), as he discusses the impacts of alcoholism on family members and friends. For more reasons to try Al-Anon, visit al-anon.org. Al-Anon members: Please remember to maintain anonymity in your comments and don't...

The Section on Neuroendocrinology focuses on the endocannabinoid system, which is involved in the regulation of appetite and the metabolism of lipids, and is therefore implicated in obesity, alcoholism and cardiovascular disease. The Section previously provided the first evidence that mice deficient in the cannabinoid receptor CB1 showed reduced food intake following temporary food deprivation. However, the use of rimonabant...

The Division of Epidemiology and Prevention Research (DEPR) promotes and supports applied, translational, and methodological research on the epidemiology and prevention of hazardous alcohol consumption and related behaviors, alcohol use disorder, alcohol-related mortality and morbidity, and other alcohol-related problems and consequences. DEPR advances its mission by: identifying scientific opportunities and gaps in current knowledge; setting research priorities; stimulating and supporting...